New Clarity Soft Tissue Visualization Software Neutralizes Organ Motion Challenges During Prostate Cancer Radiotherapy
Elekta receives FDA 510(k) clearance for Clarity 4D MonitoringStockholm, December 17, 2012 – Elekta has received 510(k) clearance for its Clarity® 4D Monitoring software, enabling U.S. medical centers to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment. Physicians will be able to monitor the motion of the prostate and surrounding tissues and organs – in real-time and with sub-millimeter accuracy – during the delivery of therapeutic radiation beams. The ability to continuously visualize the prostate’s precise location constantly